Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01727184
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
MUS | 4-METHYL-2-OXO-2H-CHROMEN-7-YL 5- (ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO- NON-2-ULOPYRANOSIDONIC ACID | A | 1S0J | 0.73 | |
FLQ | N-[6-(ACETYLAMINO)HEXYL]-3',6'- DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN- 1,9'-XANTHENE]-6-CARBOXAMIDE | C | 2FDC | 0.72 | |
AP1 | {3-[3-(3,4-DIMETHOXY-PHENYL)-1- (1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)- BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)- PROPYL]-PHENOXY}-ACETIC ACID | A,B | 1BL4 | 0.75 | |
HEH | HEDAMYCIN | A | 1JHI | 0.73 | |
C41 | ALISKIREN | C,O | 2V0Z | 0.73 | |
HMT | (3beta)-O~3~-[(2R)-2,6-dihydroxy- 2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine | 0,1,2,3,9,A, B,C,F,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 3G6E | 0.71 | |
AB8 | (1S,3R,8AS)-8-(2-{(4S,6S)-3-(4- HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)- 2-OXOETHYL]-2-OXO-1,3-OXAZINAN- 6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A- HEXAHYDRONAPHTHALEN-1-YL (2R)-2- METHYLBUTANOATE | A,B | 1XDG | 0.72 | |
DM3 | 6-DEOXYDAUNOMYCIN | A | 1D14 | 0.71 | |
MNG | MENOGARIL | A,B | 202D | 0.73 | |
CM4 | (2R,3R,4S)-3-(4-HYDROXYPHENYL)- 4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN- 6-OL | A | 1YIM | 0.7 | |
GNT | (-)-GALANTHAMINE | A | 1DX6 | 0.73 | |
GNT | (-)-GALANTHAMINE | A | 1QTI | 0.73 | |
GNT | (-)-GALANTHAMINE | A,B,C,D,E | 2PH9 | 0.73 | |
GNT | (-)-GALANTHAMINE | A,B | 1W76 | 0.73 | |
GNT | (-)-GALANTHAMINE | A | 1W6R | 0.73 | |
C61 | (2R,4S,5S,7S)-5-AMINO-N-BUTYL-4- HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]- 2,8-DIMETHYLNONANAMIDE | C,O | 2V10 | 0.73 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 215D | 0.7 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 235D | 0.7 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 234D | 0.7 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A,B | 2DES | 0.7 | |
MOI | (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A- HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2- E]ISOQUINOLINE-7,9-DIOL | H,L | 1Q0Y | 0.8 | |
DM9 | N-HYDROXYMETHYL-N-(2-METHOXYETHYL)- DAUNOMYCIN | A | 482D | 0.73 | |
DM1 | DAUNOMYCIN | A | 152D | 0.7 | |
DM1 | DAUNOMYCIN | A,B,C,D | 1O0K | 0.7 | |
DM1 | DAUNOMYCIN | A | 1JO2 | 0.7 | |
DM1 | DAUNOMYCIN | A,B | 308D | 0.7 | |
DM1 | DAUNOMYCIN | A | 1D33 | 0.7 | |
DM1 | DAUNOMYCIN | A | 110D | 0.7 | |
DM1 | DAUNOMYCIN | A | 1D11 | 0.7 | |
DM1 | DAUNOMYCIN | A | 427D | 0.7 | |
DM1 | DAUNOMYCIN | A | 2D34 | 0.7 | |
DM1 | DAUNOMYCIN | A | 3F8F | 0.7 | |
DM1 | DAUNOMYCIN | A | 1D10 | 0.7 | |
DM1 | DAUNOMYCIN | A | 1DA0 | 0.7 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D15 | 0.7 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D54 | 0.7 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D58 | 0.7 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1QDA | 0.7 | |
DM2 | DOXORUBICIN | A | 2DR6 | 0.7 | |
DM2 | DOXORUBICIN | A | 1P20 | 0.7 | |
DM2 | DOXORUBICIN | A | 1I1E | 0.7 | |
DM2 | DOXORUBICIN | A | 151D | 0.7 | |
DM2 | DOXORUBICIN | A | 1D12 | 0.7 | |
DM2 | DOXORUBICIN | A | 1DA9 | 0.7 | |
429 | 2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY- 3-HYDROXY-PHENYL)-PROPIONYLAMINO]- BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER | A | 1QXK | 0.72 | |
BDA | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AL9 | 0.7 | |
BDA | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AGL | 0.7 |